Sobrera Pharma AB

Sobrera Pharma is a biopharmaceutical company with a phase II product in development for patients with Alcohol Use Disorder

Our vision is to to make everyday life better for patients suffering from addiction disorders and other mental conditions

Alcohol addiction is a common and serious health problem for people all over the world. In Europe, about 30 million people are diagnosed with Alcohol Use Disorder/alcohol abuse, in the US this figure is about 18 million. Increased alcohol intake is strongly related to increased mortality and morbidity and every year over 3 million people die globally in alcohol related illnesses and accidents.

showing good relationships

To improve health and quality of life

Sobrera’s misson is to generate highly effective and accessible  treatments reducing the medical and social consequences of Alcohol Use Disorder. This will improve the quality of life for these patients and reduce the risk of morbidity and premature death as well as the societal costs related to alcohol abuse. The background to Sobrera takes root in the great medical need in addictive diseases and, specifically, the need for more effective treatments for patients with Alcohol Use Disorder. Read more about our research and development

Partners

University of gothenburg
GU ventures
recipharm_cmyk_nopayoff
regsmart_logo_1
vinnova_green
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search